StockVS

Vanguard Health Care Index Fund ETF Shares (VHT) ETF Analysis

Health

Vanguard Health Care Index Fund ETF Shares

$277.31

$-1.96 (-0.70%)

Last Updated: May 26, 2026

Price History

Recent News

News provided by third-party sources. Not financial advice.

Top Holdings

# Symbol Name Weight
1 LLY Eli Lilly and Co 12.59%
2 ABBV AbbVie Inc 4.94%
3 JNJ Johnson & Johnson 4.49%
4 UNH UnitedHealth Group Inc 4.09%
5 MRK Merck & Co Inc 3.83%
6 TMO Thermo Fisher Scientific Inc 3.19%
7 ABT Abbott Laboratories 3.18%
8 ISRG Intuitive Surgical Inc 2.96%
9 AMGN Amgen Inc 2.57%

Analysis

Fund Overview

The Vanguard Health Care Index Fund ETF Shares, identified by the ticker VHT, operates within the Health category and is managed by the Vanguard fund family. This specific fund currently oversees total assets under management of $20.25 billion, a figure that indicates significant scale and established popularity among investors seeking exposure to the healthcare sector. While the exact number of individual holdings is not disclosed in available data, the substantial asset base suggests a portfolio designed to track a broad index rather than focusing on a narrow set of concentrated positions. The fund maintains an expense ratio of 0.1%, which is conceptually positioned as a low-cost structure compared to many actively managed peers or funds with higher management fees.

Performance Analysis

VHT offers a current yield of 1.6%, providing a specific income component that can be relevant for investors seeking regular cash flow distributions from their equity portfolio. The fund has recorded a year-to-date return of 2.7%, reflecting its performance relative to the market benchmark during the current fiscal calendar year. Historical data shows a three-year average return of 5.7% and a five-year average return of 4.6%, metrics that illustrate the fund's consistency over different time horizons despite varying market conditions. When comparing the short-term year-to-date performance against the longer-term averages, the 2.7% YTD return is notably lower than the 5.7% three-year average, suggesting that recent market dynamics may be temporarily suppressing returns relative to the established multi-year trend. The low expense ratio of 0.1% plays a critical role in net returns over time, as minimal fees ensure that a larger portion of the fund's gross performance is retained by the shareholder rather than being consumed by operational costs.

Price & Risk Profile

The price action for VHT has fluctuated between a 52-week high of $298.61 and a 52-week low of $234.11, defining a trading range of $64.50 that indicates the degree of price volatility experienced over the last twelve months. To determine where the current price sits within this historical range, one must observe that the fund is trading below the recent highs but above the lows, implying that the price has not reached its maximum potential within the current year yet has recovered from the minimum threshold. The beta value is listed as N/A, meaning a specific volatility coefficient relative to the broader market cannot be derived from the provided metrics to quantify systematic risk exposure. Based on the available price metrics and the lack of a reported beta, the overall risk profile is characterized by the observed intrayear price swings, while the specific correlation to broader market movements remains undefined by the current data set. The expense ratio of 0.1% further supports a risk-adjusted return profile by minimizing the drag on performance that higher fees would impose on a volatile sector.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

Key Statistics

Total Assets
$18.51B
Expense Ratio
0.09%
Dividend Yield
1.72%
YTD Return
-4.96%
3-Year Avg Return
+6.39%
5-Year Avg Return
+4.59%

Data provided by Yahoo Finance via yfinance. Updated daily.

Fund Info

Category
Health
Fund Family
Vanguard
Exchange
PCX